Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial

OBJECTIVE: To evaluate the effect of colchicine and high-intensity rosuvastatin in addition to standard of care on the progression of COVID-19 disease in hospitalised patients. DESIGN: A pragmatic, open-label, multicentre, randomised controlled trial conducted from October 2020 to September 2021. Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Tayyab, McCarthy, Marianne, Nasir, Irem, Archer, Herb, Ragheb, Elio, Kluger, Jonathan, Kashyap, Nitu, Paredes, Carlos, Patel, Prashant, Lu, Jing, Kandel, Prakash, Song, Christopher, Khan, Mustafa, Huang, Haocheng, Ul Haq, Faheem, Ahmad, Rami, Howes, Christopher, Cambi, Brian, Lancaster, Gilead, Cleman, Michael, Dela Cruz, Charles, Parise, Helen, Lansky, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971831/
https://www.ncbi.nlm.nih.gov/pubmed/36828654
http://dx.doi.org/10.1136/bmjopen-2022-067910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971831/
https://www.ncbi.nlm.nih.gov/pubmed/36828654
http://dx.doi.org/10.1136/bmjopen-2022-067910

Ejemplares similares